retatrutide safety study Efficacy and of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 Retatrutide is getting attention —

Eat enough protein : It supports collagen production and maintains muscle tone

Customize monitoring to personal health and risk profile and have a knowledgeable clinician interpret

Pandis, DNP, APRN, FNP-C Share : Share : 1

Safety Monitoring and Adverse Event Management Hers providers conduct baseline screening for contraindications and advise patients on common GLP-1 side effects including nausea, vomiting, constipation, and rare pancreatitis risk

Monounsaturated, polyunsaturated and short-chain fatty acids also stimulate GLP-1 production and receptor activation

The same fundamental principles apply: gentle handling, correct diluent, proper storage